Pages

Search This Blog

Friday, July 6, 2018

Cancer link casts pall over CRISPR - MIT Technology Review

Cancer link casts pall over CRISPR - MIT Technology Review: Reports suggesting that CRISPR could cause cancer dinged the stock prices of the big three gene editing companies: Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics all fell by 10 percent or more.

No comments: